Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

632 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Genomic hallmarks of localized, non-indolent prostate cancer.
Fraser M, Sabelnykova VY, Yamaguchi TN, Heisler LE, Livingstone J, Huang V, Shiah YJ, Yousif F, Lin X, Masella AP, Fox NS, Xie M, Prokopec SD, Berlin A, Lalonde E, Ahmed M, Trudel D, Luo X, Beck TA, Meng A, Zhang J, D'Costa A, Denroche RE, Kong H, Espiritu SM, Chua ML, Wong A, Chong T, Sam M, Johns J, Timms L, Buchner NB, Orain M, Picard V, Hovington H, Murison A, Kron K, Harding NJ, P'ng C, Houlahan KE, Chu KC, Lo B, Nguyen F, Li CH, Sun RX, de Borja R, Cooper CI, Hopkins JF, Govind SK, Fung C, Waggott D, Green J, Haider S, Chan-Seng-Yue MA, Jung E, Wang Z, Bergeron A, Dal Pra A, Lacombe L, Collins CC, Sahinalp C, Lupien M, Fleshner NE, He HH, Fradet Y, Tetu B, van der Kwast T, McPherson JD, Bristow RG, Boutros PC. Fraser M, et al. Among authors: fleshner ne. Nature. 2017 Jan 19;541(7637):359-364. doi: 10.1038/nature20788. Epub 2017 Jan 9. Nature. 2017. PMID: 28068672
Nutraceuticals and prostate cancer prevention: a current review.
Trottier G, Boström PJ, Lawrentschuk N, Fleshner NE. Trottier G, et al. Among authors: fleshner ne. Nat Rev Urol. 2010 Jan;7(1):21-30. doi: 10.1038/nrurol.2009.234. Epub 2009 Dec 8. Nat Rev Urol. 2010. PMID: 19997071 Review.
DNA methylation of HOXD3 as a marker of prostate cancer progression.
Kron KJ, Liu L, Pethe VV, Demetrashvili N, Nesbitt ME, Trachtenberg J, Ozcelik H, Fleshner NE, Briollais L, van der Kwast TH, Bapat B. Kron KJ, et al. Among authors: fleshner ne. Lab Invest. 2010 Jul;90(7):1060-7. doi: 10.1038/labinvest.2010.57. Epub 2010 Mar 8. Lab Invest. 2010. PMID: 20212450 Free article.
Neoadjuvant radiotherapy for locally advanced and high-risk prostate cancer.
Thoms J, Goda JS, Zlotta AR, Fleshner NE, van der Kwast TH, Supiot S, Warde P, Bristow RG. Thoms J, et al. Among authors: fleshner ne. Nat Rev Clin Oncol. 2011 Feb;8(2):107-13. doi: 10.1038/nrclinonc.2010.207. Epub 2010 Dec 21. Nat Rev Clin Oncol. 2011. PMID: 21178999 Review.
632 results